Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Feb 9, 16:19 PM 2012 
  NYSE  8081.40  1.58  Index Moved Down   NASDAQ  2927.23  11.37  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for ACUR and CBRX...
    
  Acura Pharmaceuticals Inc.  and    Columbia Laboratories Inc.
        
    
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Acura Pharmaceuticals Inc. and Columbia Laboratories Inc. in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
-0.5
 Parameters
Time Period1 Month [change]
DirectionNegative ACUR Moved Down vs CBRX
StrengthVery Weak
Accuracy91.3%
ValuesDaily Returns
    
    

       

Acura Pharmaceuticals Inc.

    
    
3.24
  
Acura Quote
Intraday
 
Acura Intraday Quote
One Month
 0.01   Macroaxis: 0.31 Up   0.31%  
ACUR Macroaxis: United States NCMAcura Quote: Bull
Acura Pharmaceuticals Inc.
P/E16.91Day Low3.20
Open3.26P/B Ratio3.85
Market Cap146.8MVolume64940
SectorHealthcareLast Close3.23
Short Ratio27.30Last Traded2/9/2012
Year High6.80Percent ChangePrice Moved Up 0.31%
EBITDA9.6MYear Low2.28
Absolute Change0.01 Price Moved UpTimeNot Applicable
Book Value0.838EPS0.191
Day High3.31IndustryDrug Delivery
Target Price8.00Current EPS0.191
Current PE16.91This Year PENot Applicable
  

Columbia Laboratories Inc.

    
    
0.82
  
Columbia Quote
Intraday
 
Columbia Intraday Quote
One Month
(0.04)  Macroaxis: -4.12 Down   4.12%  
CBRX Macroaxis: United States NGMColumbia Quote: Bear
Columbia Laboratories Inc.
P/E5.48Day Low0.815
Open0.84P/B Ratio3.44
Market Cap71.1MVolume667428
SectorHealthcareLast Close0.85
Short Ratio9.00Last Traded2/9/2012
Year High4.31Percent ChangePrice Moved Totally Down 4.12%
EBITDA-1.3MYear Low0.64
Absolute Change0.04 Price Moved DownTimeNot Applicable
Book Value0.247EPS0.155
Employees22Day High0.85
Target Price1.50Current EPS0.155
This Year EPS0.05Next Year EPS0.05
Current PE5.48This Year PE17.00
Next Year PE17.00DividendNot Applicable